Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Mar;4(2):83-92.
doi: 10.1007/BF00053148.

Epidemiology of the M-component immunoglobulin types of multiple myeloma

Affiliations

Epidemiology of the M-component immunoglobulin types of multiple myeloma

L J Herrinton et al. Cancer Causes Control. 1993 Mar.

Abstract

The purpose of this population-based case-control study was to learn whether risk factors differ for the individual immunoglobulin types of multiple myeloma. In particular, we sought to determine whether IgA and IgG myeloma were related to a history of exposure to reported IgA- and IgG-stimulating conditions, respectively, or to a history of selected occupational and physicochemical exposures. The M-component immunoglobulin type was determined from immunoelectrophoresis as reported in medical records, and exposure status was obtained through in-person interviews. IgG (56 percent) and IgA (22 percent) M-components predominated. For 17 percent of cases, no peak was found on immunoelectrophoresis; they were presumed to have light-chain myeloma. Persons with these three types of myeloma did not differ with respect to distributions of age or race, but a somewhat higher proportion of light-chain cases were women (58 percent cf 45 percent of all other cases). Detailed analysis of the IgA and IgG subtypes provided little evidence that they differ with respect to prior immune stimulation or employment in several specific jobs. IgA myeloma, but not IgG myeloma, was associated modestly with a history of exposure to chest and dental X-rays. Our study provides little evidence that IgA and IgG myeloma differ with respect to the risk factors examined.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur Respir J. 1988 Jul;1(7):589-93 - PubMed
    1. Toxicon. 1990;28(3):347-50 - PubMed
    1. Am J Epidemiol. 1987 Dec;126(6):1051-62 - PubMed
    1. Br J Ind Med. 1992 Feb;49(2):95-103 - PubMed
    1. Eur J Haematol. 1991 Nov;47(5):333-7 - PubMed

Publication types

LinkOut - more resources